NewMed Energy - Limited (DKDRF) Fair Value & Analysis
Energy · US · Market cap $6.7B
NewMed Energy - Limited
DKDRF · US
Fair value as of: Jul 16, 2026
From 26 valuation models · updated 25 days ago
Share price +2.7% over the past month.
A solid business, but screening 45% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case ($4.75). The favourable scenario is already priced in.
- Solid but not exceptional quality (56/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range ($2.00 to $4.75) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
60‑month range $0.3872 – $7.19 · fair‑value band $2.00 – $4.75 · the $5.39 price screens above the $2.98 fair value. Dashed = 300-day average. As of Jul 16, 2026.
Analysis
NewMed Energy - Limited (DKDRF) currently trades at $5.39, while our model-based Fair Value estimate is $2.98, implying the stock looks roughly 44.7% overvalued today. The Quality Score stands at 56/100 (solid quality), in the Energy sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, NewMed Energy - Limited generated revenue of $762M at a net margin of 29.8%. Revenue declined 42.6% year over year. It earns a return on equity of 13.2%. Net debt stands at $1.3B. Fundamentals as of Jul 16, 2026
Our scenario range runs from $2.00 (bear case) to $4.75 (bull case); at $5.39, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 25% below its 52-week high and 26% above its 52-week low, currently below its 200-day average. For context, the median of 10 Energy peers we cover trades at -26% fair-value upside, at -45%, DKDRF screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings ($3.85) versus Growth DCF ($0.8200). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 57 · Market factors (momentum, volatility) 65
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
NewMed Energy - Limited Partnership exploration, development, production, and marketing of natural gas, condensate, and oil in Israel, Jordan and Egypt.
Full company description
NewMed Energy - Limited Partnership exploration, development, production, and marketing of natural gas, condensate, and oil in Israel, Jordan and Egypt. The company holds interests in the Leviathan project, which covers an area of 500 square kilometer (km2) located to the west of the shores of Haifa; the Block 12 that covers an area of approximately 386 km2 located in Cyprus; and the Yam Tethys project, located to the west of the shores of Ashkelon. It also holds interests in the Boujdour Atlantique exploration license that covers an area of approximately 33,815 km2 located in the south of the Moroccan exclusive economic zone; and the Tanin and Karish leases covering an area of approximately 500km2 located to the west of the shores of Nahariya. The company serves independent power producers, marketing companies, and industrial customers, as well as exports natural gas to Jordan and in Egypt. The company was formerly known as Delek Drilling - Limited Partnership and changed its name to NewMed Energy - Limited Partnership in February 2022. NewMed Energy - Limited Partnership was incorporated in 1993 and is based in Herzliya, Israel.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
NewMed Energy - Limited reported revenue of $1.0B in FY2025 versus $883M in FY2021, a compound +3.5%/yr. Reported net income was $343M in FY2025, compounding −4.1%/yr from FY2021.
DKDRF screens 45% overvalued. Compare with CNOOC Limited →
Peer Group
Oil & Gas E&P · 315 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Oil & Gas E&P median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Oil & Gas E&P stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| CNOOC Limited 600938 | ¥28.97 | ¥32.55 | +12% |
| ConocoPhillips explores for, COP | $109.04 | $91.79 | -16% |
| Canadian Natural Resources Limited CNQ | $42.86 | $31.54 | -26% |
| EOG Resources, Inc EOG | $139.89 | $130.19 | -7% |
| Occidental Petroleum Corporation OXY | $54.86 | $30.68 | -44% |
| Diamondback Energy, Inc FANG | $183.39 | $106.12 | -42% |
| Devon Energy Corporation DVN | $43.83 | $27.06 | -38% |
| Woodside Energy Group WDS | A$30.46 | A$20.71 | -32% |
| EQT Corporation EQT | $48.85 | $42.85 | -12% |
| Texas Pacific Land Corporation TPL | $415.70 | $79.20 | -81% |
Compare NewMed Energy - Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Energy stocks →
Frequently asked questions
Is NewMed Energy - Limited (DKDRF) overvalued or undervalued?
What is the fair value of DKDRF?
What is the quality score of DKDRF?
What is the revenue of NewMed Energy - Limited (DKDRF)?
What is the net profit margin of DKDRF?
Does NewMed Energy - Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track NewMed Energy - Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.